Modulation of 25(OH) vitamin D3 level by Imatinib mesylate in patients with chronic myelogenous leukaemia: The role of uptake and efflux transporters,

Citation:
Mervat M. Omran, Samia A. Shouman, R. Abdel Fattah, Heba S. Moussa, Nadia A. Thabet, and M. S. Hamza, "Modulation of 25(OH) vitamin D3 level by Imatinib mesylate in patients with chronic myelogenous leukaemia: The role of uptake and efflux transporters,", Current Therapeutic Research, 2022.
Tourism